Letters and Comments

Joint Comment on FDA’s Draft Guidance for Sepsis Prevention in HCT/Ps

July 7, 2025
Letters and Comments

Joint Comment on FDA’s Draft Guidance: Reducing Mtb Risk in HCT/Ps

July 7, 2025
Letters and Comments

ABC Letter to HHS Secretary Robert F. Kennedy

June 4, 2025
Letters and Comments

Blood Community Comment Letter on FDA Guidance for HCT/P Safety

April 7, 2025
Letters and Comments

Blood Community Comments on FDA’s Mtb Transmission Risk Guidance

April 7, 2025
Letters and Comments

Blood Community Comments Responding to FDA’s Proposed Malaria Testing Guidelines

March 17, 2025
Letters and Comments

ABC Supports the Freedom for Laboratory Innovation and Testing Act

March 17, 2025
Letters and Comments

Blood Community Comments to FDA on Reducing the Risk of Transmission of Hepatitis B Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

February 7, 2025
Letters and Comments

Blood Community Comments to FDA on Reducing the Risk of Hepatitis C Transmission Through Cellular and Tissue-Based Products

February 7, 2025